Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GOUT COMPRISING MORINDA CITRIFOLIA EXTRACT OR SCOPOLETIN ISOLATED THEREFROM AS AN ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2020/153608
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating gout including a Morinda citrifolia extract or scopoletin isolated therefrom as an active ingredient. Specifically, the Morinda citrifolia extract or scopoletin isolated therefrom according to the present invention exhibits xanthine oxidase inhibitory activity, DPPH radical-scavenging activity, and superoxide dismutase (SOD) activity and is capable of inhibiting uric acid production, and thus may be effectively used for gout treatment.

Inventors:
CHANG SI-YOUNG (KR)
SEO SEUNG-HYUN (KR)
KIM DAE-HWAN (KR)
CHO EUN-AI (KR)
Application Number:
PCT/KR2019/017960
Publication Date:
July 30, 2020
Filing Date:
December 18, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WELLNESSBIO INC (KR)
International Classes:
A61K36/746; A23L33/105; A61K31/37; A61K47/69; A61P19/06
Foreign References:
JP2009521407A2009-06-04
JP2007159509A2007-06-28
US20060141076A12006-06-29
KR20050120881A2005-12-26
Other References:
AFA PALU, SHIXIN DENG, BRETT WEST ,JARAKAE JENSEN: "Xanthine oxidase inhibiting effects of noni ( Morinda citrifolia ) fruit juice", PHYSIOTHERAPY RESEARCH, vol. 23, no. 12, 25 November 2009 (2009-11-25), pages 1790 - 1791, XP055723782, ISSN: 0951-418X, DOI: 10.1002/ptr.2842
Attorney, Agent or Firm:
DARAE LAW & IP, LLC (KR)
Download PDF: